Currently, the manifestations of cardiac toxicity caused by PD-1/PD-L1 immune checkpoint inhibitors include myocarditis, arrhythmia, conduction disease, myocardial infarction, pericardial disease, Takotsubo syndrome, non-inflammatory left ventricular dysfunction, etc. (13). This evidence concerns the gene CD274 and myocardial infarction.